loading page

Tranexamic acid use during thyroid surgery: A single centre retrospective analysis
  • Ayeshah Abdul-Hamid,
  • Andrew Carswell
Ayeshah Abdul-Hamid
Royal Berkshire NHS Foundation Trust
Author Profile
Andrew Carswell
Great Western Hospitals NHS Foundation Trust
Author Profile

Abstract

Key Points: • Tranexamic acid is an antifibrinolytic agent that has been used in variety of operations to reduce blood loss. • Post thyroidectomy haematoma can be life threatening, therefore multiple methods are used to reduce the risk of bleeding. • Tranexamic acid was given intra-operatively to 106 patients undergoing thyroid surgery. • Patients who received tranexamic acid had no return to theatre for post-operative haematoma (p=0.041). • There were no adverse events reported related to the administration of tranexamic acid.

Peer review status:IN REVISION

22 Aug 2020Submitted to Clinical Otolaryngology
31 Aug 2020Assigned to Editor
31 Aug 2020Submission Checks Completed
22 Sep 2020Reviewer(s) Assigned
29 Sep 2020Review(s) Completed, Editorial Evaluation Pending
03 Oct 2020Editorial Decision: Revise Major